They concluded that an overexpression of ENO1 was associated with glioma progression, while reducing ENO1 expression led to a suppression of cell growth, migration and invasion progression by inactivating the PI3K/Akt pathway in glioma cells. This evidence concerns the gene AKT1 and central nervous system cancer.